Arthrex, Inc, Smith & Nephew and DePuy Synthes are dominating the market for Global Sports Medicine Market in 2016

Global Sports Medicine Market is expected to reach USD 32,199.3 million by 2024 from USD 16,520.0 million in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Surgical devices market has the largest market segment in sports medicine market.Global Sports Medicine Market

Access full Report:

The global sports medicine market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Arthrex, Inc dominated the sports medicine market accounting for a highest market share in 2016, followed by Smith & Nephew, DePuy Synthes, Stryker Corporation, CONMED Corporation. Other players in this market include Johnson & Johnson, Bird & Cronin, Inc., Zimmer, Inc., Biomet Inc., Anika Therapeutics, Ossur, Breg Inc., Mueller Sports Medicine, Inc., DJO global, Medtronic among others holds 25% of the global sports medicine market in 2016.

Arthrex, Inc.:

Founded in 1981 as Arthrex, Inc and head quartered in Florida, U.S. is engaged in the development and marketing of orthopaedics products. The company operates through only one business segment namely orthopaedics.

Smith &Nephew:

Incorporated in June 1856 and headquartered in London, United Kingdom Pfizer Inc., is engaged in the development and marketing of medical products and services. The company operates through four business segments, such as sports medicine, advanced wound care management, orthopaedic reconstruction, and trauma and extremities. . The sports medicine segment offers a wide range of technologies or implants for repair of soft tissue injuries, fluid management equipment for surgical access, digital cameras, digital image capture, scopes, light sources and monitors to assist with visualization, radiofrequency wands, electromechanical and mechanical blades and, hand instruments for resecting damaged tissue.

Recent Developments:

1. In January 2016, Smith & Nephew acquired first line cartilage repair product known as BST-CarGelused along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears.

2. In June 2015, Smith & Nephew acquired Zimmer’s Unicondylar Knee system (ZUK) in U.S. market. ZUK is a clinically proven uni knee replacement introduced globally in 2004. Smith & Nephew has purchased all existing inventory and certain intellectual property for the U.S. market.

Stryker Corporation:

Founded in 1941 and headquartered in Michigan, U.S., Stryker Corporation specializes in reconstructive, medical and surgical, and neurotechnology and spine products. The company has three business segments—orthopedic implants, MedSurg, and neurotechnology and spine.

Recent Developments:

1. In November 2016, Stryker announced a multi-year collaboration with Indo UK Institute of Health's (IUIH) Medicity Program to serve as a preferred partner in the orthopedic areas of hip, knee, and trauma products and services. Stryker and IUIH's new relationship will provide greater access to affordable primary joint replacements and other healthcare services to patients in India.

2. In April 2016, Stryker Corporation acquired Physio-Control International, Inc. Physio-Control develops, manufactures and markets monitors/defibrillators, automated external defibrillators (AEDs) and CPR-assist devices along with data management and support services.